Krispy Kreme Doughnuts, Inc. Message Board
-
Yup, there just in the business of giving away/losing $500 million dollars. LOL :-) If Goldman is in the house, the game is PREDETERMINED, always is. Short away, your just spiting in the wind. :-)
-
LOL:-). Think about it :-). You think you're smarter than GS. Way too funny!!
-
Been hearing that same UNENLIGHTENED thinking here for years and years. Expect it will continue as we revolutionize/disrupt the car/ev industry. LOL :-)
-
I hope that's the case, that they have their, Marissa Mayer all lined up. Better person became available, and they went with the better Jockey. I hope. :-)
-
Shorts are so clueless. They mistakenly think $500 million is real money, BECAUSE they fail to understand, it is ALWAYS relative to the victory/prize that is earned. :-)
Google article title if interested, "Goldman Finances Huge SolarCity Push to Build Panels" -
Didn't the Japanese invade your country and teach you how to behave?
-
Sorry, TSLA. :-) Just opend a second bottle of Chard. BIG :-)
-
Just ask NOballsCoach. Why do you think they call him NOballs. He shorted TSAL. LOL :-)
-
Baker bros. bought 1.9 million shares. :-)
-
Earth to SHORTS, are you still there. LOL :-)
- Reply to
HALO, 42% of Panceatic cancer patients saw their tumors shrink 48%
by networthdev •May 16, 2013 11:31 AMThis will get us some ATTENTION, and given we have over 2.75 million shares traded, THIS MORNING, feels like that visibility is BEGINNING.
-
Etrade FLASH
42% of Panceatic cancer patients saw their tumors shrink 48%, no tiny feat in a disease which kills 78% of those afflicted in 5 years. -
Are you figuring it out YET shorty!!! LOL :-)
-
Take that SHORTY. You guys need your heads examined. TSLA is destined to GREATNESS.
Over and out. -
This is EXCELLENT as well. Doc's are finding EXPANDED indications/MARKETS for our device....ALREADY!!
"The Company is also pleased to report that it is aware of early stage work being done by a U.S. center evaluating the use of C-Pulse as a technology for Fontan Mechanical Assistance for patients born with single ventricles. In addition, Sunshine Heart has been approached by a separate center that is interested in conducting pre-clinical studies to evaluate C-Pulse as a non-blood contacting right ventricular assist device. Information regarding progress of these potential therapeutic indications for C-Pulse will be provided as data becomes available." -
SSH deserves this designation!!!!
-
From the quarterly:
"Following the positive 12-month follow up data for the C-Pulse feasibility study announced at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference, the Company expects to submit the trial manuscript titled, "Ambulatory Extra-Aortic Counterpulsation in Patients with Moderate to Advanced Chronic Heart Failure," to a major medical journal for publication." -
This will draw more KNOWLEDGEABLE investors.
From the quarterly:
"Following the positive 12-month follow up data for the C-Pulse feasibility study announced at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference, the Company expects to submit the trial manuscript titled, "Ambulatory Extra-Aortic Counterpulsation in Patients with Moderate to Advanced Chronic Heart Failure," to a major medical journal for publication."
"The Company is also pleased to report that it is aware of early stage work being done by a U.S. center evaluating the use of C-Pulse as a technology for Fontan Mechanical Assistance for patients born with single ventricles. In addition, Sunshine Heart has been approached by a separate center that is interested in conducting pre-clinical studies to evaluate C-Pulse as a non-blood contacting right ventricular assist device. Information regarding progress of these potential therapeutic indications for C-Pulse will be provided as data becomes available."
"Sunshine Heart is currently in discussions with physicians regarding the potential weaning of additional patients from the C-Pulse system, based upon significant improvements since the time of implant. To-date, two patients implanted in the Company's Feasibility study have been permanently weaned from the device. The Company expects to report on the status of these additional patients in the coming months, as appropriate." -
Nice try, get ready for Monday. LOL. :-)
-
It's OLD news, the company only has 23 million shares outstanding.